KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to -$76.1 million.

  • West Pharmaceutical Services' Cash from Investing Activities rose 2738.55% to -$76.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$285.9 million, marking a year-over-year increase of 2450.49%. This contributed to the annual value of -$285.9 million for FY2025, which is 2450.49% up from last year.
  • As of Q4 2025, West Pharmaceutical Services' Cash from Investing Activities stood at -$76.1 million, which was up 2738.55% from -$63.3 million recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' Cash from Investing Activities registered a high of -$54.5 million during Q1 2021, and its lowest value of -$108.8 million during Q4 2023.
  • Over the past 5 years, West Pharmaceutical Services' median Cash from Investing Activities value was -$76.8 million (recorded in 2021), while the average stood at -$78.7 million.
  • In the last 5 years, West Pharmaceutical Services' Cash from Investing Activities plummeted by 7084.64% in 2021 and then surged by 2738.55% in 2025.
  • Over the past 5 years, West Pharmaceutical Services' Cash from Investing Activities (Quarter) stood at -$77.4 million in 2021, then dropped by 22.48% to -$94.8 million in 2022, then dropped by 14.77% to -$108.8 million in 2023, then increased by 3.68% to -$104.8 million in 2024, then increased by 27.39% to -$76.1 million in 2025.
  • Its last three reported values are -$76.1 million in Q4 2025, -$63.3 million for Q3 2025, and -$75.2 million during Q2 2025.